Keywords
Toxoplasmosis, HIV/AIDS, opportunistic infections
Abstract
Toxoplasma gondii infection is one of the common and dangerous opportunistic infections in HIV-infected patients, especially when CD4 cell counts are < 100 cells/mm³. The disease often manifests as encephalitis caused by Toxoplasma gondii, resulting in high mortality and neurological sequelae if not diagnosed and treated promptly. Diagnosis of Toxoplasma gondii infection in HIV patients remains challenging due to nonspecific clinical manifestations, limitations in specialized diagnostic tools, and overlap with other neurological conditions. This paper aims to review current literature on the diagnosis and treatment of Toxoplasmosis in HIV patients and discuss its application in clinical practice at Viet Tiep Hospital.
References
[1]
. Kochanowsky, J.A. and A.A. Koshy, Toxoplasma gondii. Current Biology, 2018. 28(14): p. R770-R771.
Google Scholar
[2]
. Lê Đỗ Đình Nguyên, Du Trọng Đức, Hoàng Trường, Lê Văn Tấn et all , Khối choán chỗ nội sọ ở bệnh nhân nhiễm HIV/AIDS - Nghiên cứu mô tả loạt ca bệnh tại Bệnh viện Bệnh Nhiệt đới Trung ương. Tạp chí Truyền nhiễm Việt Nam. , 2022. 3(39): p. 45-51.
Google Scholar
[3]
. Bộ Y tế, Hướng dẫn chẩn đoán và điều trị HIV/AIDS ban hành kèm theo quyết định số 3003/QĐ-BYT ngày 19/08/2009. 2009.
Google Scholar
[4]
. Nguyễn Kim Thư, Nguyễn Hải Yến, Phạm Ngọc Thạch , Căn nguyên nhiễm trùng thường gặp ở bệnh HIV/AIDS sốt kéo dài (1/2016-6/2019). Tạp chí Truyền nhiễm Việt Nam 2020. 2: p. 89-94.
Google Scholar
[5]
. Lee, K.H., A. Jiamsakul, S. Kiertiburanakul, R. Borse, V. Khol, E. Yunihastuti, I. Azwa, I.K.A. Somia, R. Chaiwarith, T.N. Pham, S. Khusuwan, C.D. Do, N. Kumarasamy, Y. Gani, R. Ditangco, O.T. Ng, S. Pujari, M.P. Lee, A. Avihingsanon, H.P. Chen, F. Zhang, J. Tanuma, J. Ross, and J.Y. Choi, Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region. PLoS One, 2024. 19(7): p. e0306245.
Google Scholar
[6]
. Montoya, J.G. and O. Liesenfeld, Toxoplasmosis. The Lancet, 2004. 363(9425): p. 1965-1976.
Google Scholar
[7]
. Jones, J.L., D. Kruszon-Moran, H.N. Rivera, C. Price, and P.P. Wilkins, Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg, 2014. 90(6): p. 1135-9.
Google Scholar
[8]
. Baratloo, A.U., B.U. Hashemi, A.U. Rouhipour, P.U. Haroutunian, and M.U. Mahdlou: Toxoplasmic Encephalitis in an AIDS Patient with Normal CD4 Count: A Case Report. Iran J Parasitol. 2018 Apr-Jun;13(2):317-322.
Google Scholar
[9]
Tanuma, J. Ross, and J.Y. Choi, Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region. PLoS One, 2024. 19(7): p. e0306245.
Google Scholar
[10]
. Montoya, J.G. and O. Liesenfeld, Toxoplasmosis. The Lancet, 2004. 363(9425): p. 1965-1976.
Google Scholar
[11]
. Jones, J.L., D. Kruszon-Moran, H.N. Rivera, C. Price, and P.P. Wilkins, Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg, 2014. 90(6): p. 1135-9.
Google Scholar
[12]
. Baratloo, A.U., B.U. Hashemi, A.U. Rouhipour, P.U. Haroutunian, and M.U. Mahdlou: Toxoplasmic Encephalitis in an AIDS Patient with Normal CD4 Count: A Case Report. Iran J Parasitol. 2018 Apr-Jun;13(2):317-322.
Google Scholar
[13]
. Ngo Van An, Nong Minh Vuong, Clinical characteristics, laboratory findings and outcomes of Toxoplasma gondii infection in HIV/AIDS patients at Bach Mai Hospital. Journal of Clinical Medicine, 2021. 7(Special): p. 87-101.
Google Scholar
[14]
. Prosty, C., R. Hanula, Y. Levin, Bogoch, II, E.G. McDonald, and T.C. Lee, Revisiting the Evidence Base for Modern-Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis. Clin Infect Dis, 2023. 76(3): p. e1302-e1319.
Google Scholar